Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
General Practice Physician in Vega Alta, PR
NPI: 1386723518HQ Phone
Get Angelic's Phone Numberphone_androidMobile
Get Angelic's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPR State Medical License
PR State Medical License
2001 - 2025
University of Puerto Rico
Internship • Emergency Medicine
2000 - 2001
Universidad Autonoma de Guadalajara
Medical School
Until 2000
Authors: Felip, Enriqueta, Ardizzoni, Andrea, Ciuleanu, Tudor, Cobo, Manuel, Laktionov, Konstantin, Szilasi, Maria, Califano, Raffaele, Carcereny, Enric, Griffiths, Richard, Paz-Ares, Luis, Duchnowska, Renata, Garcia, Miriam Alonso, Isla, Dolores, Jassem, Jacek, Appel, Wiebke, Milanowski, Janusz, Van Meerbeeck, Jan P, Wolf, Juergen, Li, Ang, Acevedo, Angelic, Popat, Sanjay
Journal: Eur J Cancer
Publication Date: 2020-02-03
Authors: Neal Ready, David Spigel
Journal: J Immunother Cancer
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations.
Authors: Enriqueta Felip, Andrea Ardizzoni, Tudor Ciuleanu, Manuel Cobo, Konstantin Laktionov, Maria Szilasi, Raffaele Califano, Enric Carcereny, Richard Griffiths, Luis Paz Ares, Renata Duchnowska, Miriam Garcia, Dolores Isla, Jacek Jassem, Wiebke Appel, Janusz Milanowski, Jan Van Meerbeeck, Juergen Wolf, Ang Li, Angelic Acevedo, Sanjay Popat
Publication Date: 2019-11-08
Lead Sponsor: Bristol-Myers Squibb
Collaborators: Eisai Inc.
Intervention / Treatment: DRUG: MORAb-202, DRUG: Paclitaxel, DRUG: Topotecan, DRUG: Pegylated Liposomal Doxorubicin (PLD)
Lead Sponsor: Mirati Therapeutics Inc.
Intervention / Treatment: DRUG: MRTX849, DRUG: MRTX0902
Lead Sponsor: Mirati Therapeutics Inc.
Intervention / Treatment: BIOLOGICAL: Cetuximab, DRUG: MRTX849, DRUG: mFOLFOX6 Regimen, DRUG: FOLFIRI Regimen